Regeneron Pharmaceuticals
REGN
REGN
1,190 hedge funds and large institutions have $76.1B invested in Regeneron Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 131 funds opening new positions, 440 increasing their positions, 421 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 1,157 → 1,190 (+33)
5% more repeat investments, than reductions
Existing positions increased: 440 | Existing positions reduced: 421
8% less call options, than puts
Call options by funds: $1.93B | Put options by funds: $2.09B
Holders
1,190
Holding in Top 10
42
Calls
$1.93B
Puts
$2.09B
Top Buyers
| 1 | +$3.43B | |
| 2 | +$1.39B | |
| 3 | +$470M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$343M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$318M |
Top Sellers
| 1 | -$1.25B | |
| 2 | -$1.12B | |
| 3 | -$489M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$311M |
| 5 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
-$201M |